Yamazumi K, Terukina S, Onohara S, Matsuda M
Division of Hemostasis and Thrombosis Research, Jichi Medical School, Tochigi-Ken, Japan.
Thromb Haemost. 1988 Dec 22;60(3):476-80.
We have identified a gamma-Arg-275 to His substitution in an abnormal fibrinogen designated as "fibrinogen Saga" characterized by impaired fibrin monomer polymerization. By chromatofocusing chromatography, we isolated normal and abnormal fragment D1 populations separately from the plasmic-calcium digests of fibrinogen derived from the propositus, a heterozygote for the abnormality. We found that both normal and abnormal fragment D1's were similarly protected from digestion by plasmin in the presence of calcium ions and further degraded to fragments D2 and D3 due to cleavage of the gamma-chain remnant when calcium ions were replaced by chelating agents. Abnormal fragment D1 failed to inhibit both thrombin-clotting of normal fibrinogen and polymerization of normal fibrin monomer, while normal D1 exhibited marked inhibitory activities. In an aberrant peptide comprising residues gamma-274-302 isolated by HPLC from the lysyl endopeptidase-digests of abnormal fragment D1, we identified a His substituting for an Arg at position 2, which corresponds to position 275 of the mutant gamma-chain.
我们在一种被命名为“纤维蛋白原佐贺”的异常纤维蛋白原中鉴定出γ-精氨酸275被组氨酸取代的情况,其特征为纤维蛋白单体聚合受损。通过色谱聚焦层析,我们从先证者(该异常的杂合子)来源的纤维蛋白原的血浆钙消化物中分别分离出正常和异常的片段D1群体。我们发现,在钙离子存在的情况下,正常和异常的片段D1对纤溶酶消化的保护作用相似,而当钙离子被螯合剂取代时,由于γ链残余物的裂解,它们会进一步降解为片段D2和D3。异常片段D1未能抑制正常纤维蛋白原的凝血酶凝血以及正常纤维蛋白单体的聚合,而正常D1则表现出显著的抑制活性。在通过HPLC从异常片段D1的赖氨酰内肽酶消化物中分离出的包含γ-274 - 302残基的异常肽段中,我们鉴定出在第2位有一个组氨酸取代了精氨酸,该位置对应于突变γ链的第275位。